Natural signal holds promise for psoriasis, age-related skin damage

Key points
- The body may hold a secret to normalizing skin cell growth that is over zealous in psoriasis and non-melanoma skin cancers and too slow in aging and sun-damaged skin, researchers say.
- Phosphatidylglycerol, a natural body lipid or fat, appears to signal cells to normalize growth and maturation or differentiation.
- "When we apply it to skin cells, we see the normalization ability," says Dr.
- Her research, published online in The Journal of Investigative Dermatology, helps piece together the signaling pathway that prompts skin cells to stop multiplying and start differentiating.
The body may hold a secret to normalizing skin cell growth that is over zealous in psoriasis and non-melanoma skin cancers and too slow in aging and sun-damaged skin, researchers say.
Phosphatidylglycerol, a natural body lipid or fat, appears to signal cells to normalize growth and maturation or differentiation.
"When we apply it to skin cells, we see the normalization ability," says Dr. Wendy B. Bollag, cell physiologist at the Medical College of Georgia.
Her research, published online in The Journal of Investigative Dermatology, helps piece together the signaling pathway that prompts skin cells to stop multiplying and start differentiating.
Perhaps most importantly it shows that bypassing that pathway – one researchers suspect becomes dysfunctional in diseases like psoriasis – and giving the signal itself restores normal differentiation of skin cells or keratinocytes.
The findings prompted Dr. Bollag and John Edwards, CEO of Apeliotus Technologies of Atlanta, to seek National Institutes of Health funding for yearlong study in animal models of mild psoriasis to see if it works, with human trials as the goal. "Proof of principle is the first phase. If in vivo data looks promising, we'll put together a study we can take into the clinic," says Dr. Bollag. She and Apeliotus received an NIH Small Business Technology Transfer grant, which supports small businesses collaborating with U.S. research institutions to develop technologies and methodologies with commercial potential.
A Georgia Research Alliance Industry Partnership Grant will allow parallel studies in animal models of chronological aging and photoaging from too much sun exposure, Dr. Bollag says.
MCG and Apeliotus will work with Avanti® Polar Lipids, Inc., of Alabaster, Ala., which has a chicken-egg derived phosphatidylglycerol used primarily for lipid research. Avanti is developing different phosphatidylglycerol ointments or salves for the new studies. Dr. Bollag notes that the lipid, already used as drug-delivery mechanism in humans, has been ingested at higher doses, so she believes lower doses applied externally will be safe.
Glycerol, a precursor of phosphatidylglycerol, also is available commercially and used in many skin care products because it's long been known to help skin retain moisture, so it looks and feels better. "We think that, yes, it's a water attractor, but we think it also has this additional role as a precursor for an important lipid signal in the skin," says Dr. Bollag. Naturally occurring glycerol is an important precursor for many things such as fat, phospholipids, various sugars and metabolic pathways in the body. "Glycerol levels go up when you exercise, because you are using fats as fuel."
She's shown that the channel, aquaporin-3, delivers glycerol to phospholipase D, resulting in the skin cell differentiation signal, phosphatidylglycerol. "This is serving as a signal, like an elevator operator who says, ‘This way for normal keratinocyte differentiation,'" says Dr. Bollag. "That's good because without it, you get abnormal differentiation in skin diseases like psoriasis, non-melanoma skin cancer, some of the dermatitises; in a lot of these conditions, the cells proliferate too much and don't differentiate properly. We think maybe in psoriasis, the phospholipase D and aquaporin-3 become disconnected so now they can't produce phosphatidylglycerol. If you only put glycerol on it, it may not help."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Skin, Hair & Beauty →
NewsExtended Raptiva therapy safe, effective for psoriasis
Treatment with the relatively new drug Raptiva for 12 weeks has been shown to be a safe and effective treatment for moderate-to-severe chronic psoriasis. Now, new research indicates that the benefits are even more…
20 January 2005
NewsPlaque Psoriasis
This is the most common type of psoriasis. It typically appears as thick, flaky patches of skin on one or more parts of the body. Sometimes the patches of affected skin are large, extending over much of the body. The…
10 January 2005
NewsPsoriasis my yield to modified anti-anxiety drug
A new benzodiazepine derivative, called Bz-423, holds promise for treating psoriasis without being toxic to normal cells, a research team at the University of Michigan in Ann Arbor reports. Psoriasis is a scaly skin…
18 December 2004